Purchase
Description
Ofatumumab biosimilar is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody is produced in a recombinant CHO cell line using standard mammalian cell cultivation and purification technologies.
Ofatumumab biosimilar is supplied at a concentration of 20 mg/mL as a sterile, clear to opalescent, colorless, preservative-free liquid of pH 5.5, which contains 10 mg/mL arginine, diluted hydrochloric acid, 0.019 mg/mL edetate disodium, 0.2 mg/mL polysorbate 80, 6.8 mg/mL sodium acetate, 2.98 mg/mL sodium chloride.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Ofatumumab biosimilar
|
|
CAS
NO.
|
679818-59-8
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
CD20
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
149 kDa
|
|
Formula
|
C6480H10022N1742O2020S44
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154576647664.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Ofatumumab
|
